Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamate
Authors:
- 1 November 2004
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 372 (1-2) , 110-113
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Neurotransmitters of the retino-hypothalamic tractCell and tissue research, 2002
- Distribution and daily variations of PACAP in the chicken brainPeptides, 2001
- BDNF mediates the neuroprotective effect of PACAP-38 on rat cortical neuronsNeuroReport, 2001
- Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP), a Neuron-Derived Peptide Regulating Glial Glutamate Transport and MetabolismJournal of Neuroscience, 2000
- Perspectives on Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) in the Neuroendocrine, Endocrine, and Nervous SystemsThe Japanese Journal of Physiology, 1998
- Pituitary adenylate cyclase-activating polypeptide protects rat-cultured cortical neurons from glutamate-induced cytotoxicityBrain Research, 1996
- Characterization of Ocular Receptors for Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and their Coupling to Adenylate CyclaseExperimental Eye Research, 1994
- Neurotoxic effects of neonatal injections of monosodium L‐glutamate (L‐MSG) on the retinal ganglion cell layer of the golden hamster: Anatomical and functional consequences on the circadian systemJournal of Comparative Neurology, 1993
- Synaptic contacts of serotonin-like immunoreactive and 5,7-dihydroxytryptamine-accumulating neurons in the anuran retinaNeuroscience, 1993
- Kainic acid affects both plexiform layers of chicken retinaNeuroscience Letters, 1981